Mayne Pharma appoints new CFO
Mayne Pharma (ASX:MYX) appointed Griffin D. Buchanan as CFO, effective Aug. 1.

Finance journalist at Grafa. Covers tech, crypto, and markets, making complex finance clear for all. Passionate about innovation and trends.
Mayne Pharma (ASX:MYX) appointed Griffin D. Buchanan as CFO, effective Aug. 1.
MoonPay has acquired Glide to expand its cryptocurrency deposit capabilities and simplify how users transfer digital assets into wallets.
Robinhood paused trading of the Vladfun (CRYPTO:VLAD) memecoin after concerns emerged over its launch and links to Robinhood Chain.
SkyCity Entertainment (ASX:SKC) finalises an unconditional NZ$74.5 million sale of its Auckland office and investment properties.
Apple (NASDAQ:AAPL) received approval from the Cyberspace Administration of China to launch its generative AI services in the country by integrating models from Alibaba (NYSE:BABA) and Baidu (NASDAQ:BIDU).
Prologis (NYSE:PLD) reported strong second quarter 2026 results and raised its full-year guidance after signing over 67 million square feet of leases.
ManpowerGroup (NYSE:MAN) reported second-quarter 2026 revenues of $4.9 billion and net earnings of $53.5 million.
U.S. Bancorp (NYSE:USB) reported Q1 2026 net revenue of $7.288 billion and diluted EPS of $1.18, exceeding the $1.14 analyst estimate.
Immuron (NASDAQ:IMRN) reported unaudited FY26 global Travelan sales of AUD$7.7 million, representing year-over-year growth of 6%.
Taiwan Semiconductor Manufacturing Company (NYSE:TSM) plans another $100 billion of U.S. manufacturing investment, bringing its total announced commitment to $265 billion.